CIK 0001579428 · Large accelerated filer
Axsome Therapeutics, Inc.
Sign in to watch- Ticker
- AXSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 454241907
- Phone
- (212) 332-3241
- Business address
- ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK, NY, 10007
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Other events
- DEF 14A Proxy Proxy Statement
- 8-K Event Other events
- 8-K Event Results of operations · Other events
- 10-K Report Annual Report
- 8-K Event Other events
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy Chief Medical Officer bought 1,000 shares at $9.03 ($9,026)
- CT ORDER Other Confidential Order
- S-8 Other Securities Offered to Employees in Benefit Plans
- SC 13G Stake Amended Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- 4 Conversion Vice President, Finance acquired 4,358 shares (conversion)
- 4 Conversion Chief Medical Officer acquired 5,022 shares (conversion)
- 4 Conversion Director acquired 564,948 shares (conversion)
- 4 Conversion Director acquired 4,374 shares (conversion)
Page 32 of 34 · 672 filings